The First Affiliated Hospital of University of South China

Hengyang, Hunan 421001

2 studies enrolling now · 5 studies all time

What they study most

Heart Failure, Melanoma, Nasopharyngeal Carcinoma, Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer, Renal Cell Carcinoma, Ulcerative Colitis

Studies at this site

• A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors — Recruiting now
• Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients — Recruiting now
• A Study of Ponsegromab in People With Heart Failure — Stopped early
• ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1 — Completed
• A Study of Penpulimab (AK105) in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma — Running, not enrolling